ArticleGenes & development2017
Settling the m
Article in Genes & development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 34 citations in OpenAlex.
- Review
- ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through mCell reports · 2023Article
- The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches.Cancers · 2023Review
- mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.Cardiovascular research · 2022Review
- Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells.Genes & development · 2022Review
- The role of RNA modification in hepatocellular carcinoma.Frontiers in pharmacology · 2022Review
- Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.Journal of cellular and molecular medicine · 2021Article
- Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution.Nature methods · 2021Article
- Epitranscriptomics of Ischemic Heart Disease-The IHD-EPITRAN Study Design and Objectives.International journal of molecular sciences · 2021Article
- SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.Nucleic acids research · 2021Article
- The role of RNA epigenetic modification in normal and malignant hematopoiesis.Current stem cell reports · 2020Article
- Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.The Kaohsiung journal of medical sciences · 2020Article
- Limits in the detection of mScientific reports · 2020Article
- Contribution of m6A subtype classification on heterogeneity of sepsis.Annals of translational medicine · 2020Article
- Occurrence and Functions of mPlant physiology · 2020Article
- Atlas of quantitative single-base-resolution NNature communications · 2019Article
- The dynamics of FTO binding and demethylation from the mRNA biology · 2019Article
- The role of mMolecular cancer · 2019Review
- Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.EMBO reports · 2018Review
- Adenosine methylation as a molecular imprint defining the fate of RNA.FEBS letters · 2018Review
Corrections and comments
- Comment onm2017
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-transcriptional modification of RNA nucleosides has been implicated as a pivotal regulator of mRNA biology. In this issue of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.